Crocs

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Nearest Resistance: $14

Nearest Support: N/A

Catalyst: Outlook Miss

While earnings have been overwhelmingly positive today, Crocs ( CROX) is getting shellacked after posting poor outlook numbers to the market. As I write, shares of the shoemaker are down more than 20%.

>>5 Toxic Stocks to Sell Now

It wasn't more than a handful of years ago that Crocs was the momentum stock of the day, taking off into the stratosphere as investors extrapolated its breakneck growth into the future. But clearly, that hasn't been the case -- and now, downside momentum is what makes Crocs stand out.

From a technical standpoint, this stock couldn't look much weaker. Today's move sent shares through their nearest support level at $14 (now a resistance level) to new 52-week lows in the high $12s. Until CROX can catch a bid, I wouldn't touch it. You shouldn't either.

To see these stocks in action, check out the at Most-Active Stocks portfolio on Stockpickr.

-- Written by Jonas Elmerraji in Baltimore.

RELATED LINKS:



Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Jonas Elmerraji is the editor and portfolio manager of the Rhino Stock Report, a free investment advisory that returned 15% in 2008. He is a contributor to numerous financial outlets, including Forbes and Investopedia, and has been featured in Investor's Business Daily, in Consumer's Digest and on MSNBC.com.

If you liked this article you might like

PSS World Medical Stock Hits New 52-Week High (PSSI)

PSS World Medical Reaches New 52-Week High (PSSI)

PSS World Medical Stock Hits New 52-Week High (PSSI)

Stocks Finish With Mild Gains